Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial

Journal of Hepatology

Volumn 25, Issue 2, 1996, Pages 135-144

  Lebrec, Didier ^a   Giuily, Nathalie ^a   Hadengue, Antoine ^a   Vilgrain, Valérie ^a   Moreau, Richard ^a   Poynard, Thierry ^a   Gadano, Adrián ^a   Lassen, Claudine ^a   Benhamou, Jean Pierre ^a   Erlinger, Serge ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Ascites; Cirrhosis; Diuresis; Intrahepatic shunt; Natriuresis; Portal hypertension

Indexed keywords

DIURETIC AGENT;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; FEMALE; HORMONAL REGULATION; HUMAN; LIVER CIRRHOSIS; MALE; NATRIURESIS; PARACENTESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 9444257018     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80065-1     Document Type: Article

References (34)

1. Dudley F.J., Watanabe A. Management of ascites. J Gastroenterol Hepatol. 7:1992;439-446.
2. Runyon B.A. Refractory ascites. Semin Liver Dis. 13:1993;343-351.
3. Ginès P., Arroyo V., Rodés J. Pharmacotherapy of ascites associated with cirrhosis. Drugs. 43:1992;316-332.
4. Stanley M.M., Ochi S., Lee K.K., Nemchausky B.A., Greenlee H.B., Allen J.I., Allen M.J., Baum R.A., Gadacz T.R., Camara D.S., Caruana J.A., Schiff E.R., Livingstone A.S., Samanta A.K., Najem A.Z., Glick M.E., Juler G.L., Adham N., Baker J.D., Cain G.D., Jordan P.H., Wolf D.C., Fulenwider J.T., James Ke. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med. 321:1989;1632-1638.
5. Ginès P., Arroyo V., Vargas B., Planas R., Casafont F., Panés J., Hoyos M., Viladommiu L., Rimola A., Morillas R., Salmeron J.M., Ginès A., Esteban R., Rodés J. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 325:1991;829-835.
6. Franco D., Vons C., Traynor O., De Smadja C. Should porto-systemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg. 123:1988;987-991.
7. Pomier-Layrargues M., Legault L., Row L., Dufresne P.M., Lafortune M., Fenyves D. TIPSS for treatment of refractory ascites: a pilot study. Hepatology. 18:1993;103A. abstract.
8. Ferral H., Bjarnason H., Wegryn S.A., Rengel G.J., Nazarian G.K., Rank J.M., Tadavarthy S.M., Hunter D.W., Castaneda-Zuniga W.R. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology. 189:1993;795-801.
9. Ochs A., Rössle M., Haag K., Hauenstein K.H., Deibert P., Siegerstetter V., Huonker M., Langer M., Blum H.E. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med. 332:1995;1192-1197.
10. Quiroga J., Sangro B., Nunez M., Bilbao I., Longo J., Garcia-Villareal L., Zozaya J.M., Betés M., Herrero J.I., Prieto J. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 21:1995;986-994.
11. Somberg K.A., Lake J.R., Tomlanovich J., Laberge J.M., Feldstein V., Bass N.M. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology. 21:1995;709-716.
12. Wong F., Sniderman K., Liu P., Allidina Y., Sherman M., Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med. 122:1995;816-822.
13. Caesar J., Shaldon S., Chiandussi L., Guevara L., Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 21:1961;43-57.
14. Calès P., Braillon A., Jiron M.I., Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol. 1:1984;37-46.
15. Brown H.S.S., Halliwell M., Qamar M., Read A.E., Evans J.M., Wells P.N.T. Measurement of normal portal venous blood flow by Doppler ultrasound. Gut. 30:1989;503-509.
16. Carlisle K.M., Halliwell M., Read A.D., Wells P.N.T. Estimation of total hepatic blood flow by duplex ultrasound. Gut. 33:1992;92-97.
17. Moreau R., Gaudin C., Hadengue A., Braillon A., Roulot D., Bacq Y., Lebrec D. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Nephron. 65:1993;359-363.
18. Hjemdahl P. Catecholamine measurements by high-performance liquid chromatography. Am J Physiol. 247:1984;E13-E20.
19. Bichet D.G., Kortas C., Mettauer B., Manzini C., Marc-Aurèle J., Rouleau J.L., Schrier R.W. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int. 29:1986;1188-1196.
20. Sanyal A.J., Freedman A.M., Purdum P.P., Luketiic V.A., Shiffman M.L., Tisnado J., Cole P. Transjugular intrahepatic porto-systemic shunt (TIPS) vs sclerotherapy for prevention of recurrent variceal hemorrhage: a randomized prospective trial. Gastroenterology. 106:81994;A975. abstract.
21. Jalan R., Elton R.A., Redhead D.N., Finlayson N.D.C., Hayes P.C. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 23:1995;123-128.
22. Freedman A.M., Sanyal A.J., Tisnado J., Cole P.E., Shiffman M., Luketic V.A., Purdum P.P., Darcy M.D., Posner M.P. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics. 13:1993;1185-1210.
23. Nazarian G.K., Ferral H., Castaned-Zuniga W.R., Bjarnason H., Foshager M., Rank J.M., Anderson C.A., Rengel G.J., Herman M.E. Development of stenoses in transjugular intrahepatic portosystemic shunt. Radiology. 192:1994;231-234.
24. Lind C.D., Malisch T.W., Chong W.K., Richards W.O., Pinson C.W., Meranze S.G., Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology. 106:1994;1277-1283.
25. Sanyal A.J., Freedman A.M., Shiffman M.L., Purdum P.P., Luketic V.A., Cheartham A.K. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 20:1994;46-55.
26. Hadengue A., Moureau R., Sogni P., Soupison T., Vilgrain V., Lebrec D. Risk of adverse hemodynamic effects after intrahepatic shunts (TIPS): preliminary results. Hepatology. 16:1992;241A. abstract.
27. Azoulay D., Castaing D., Dennison A., Martino W., Eyraud D., Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology. 19:1994;129-132.
28. Reynolds T.B. The role of hemodynamic measurements in portosystemic shunt surgery. Arch Surg. 108:1974;176-181.
29. Braillon A., Lee S.S., Girod C., Peignoux-Martinot M., Valla D., Lebrec D. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat. J Lab Clin Med. 108:1986;543-548.
30. Colombato L.A., Martinet J.P., Dufresne M.P., Fenyves D., Lafortune M., Pomier-Layrargues G. Reversal of the initial increase in cardiac index with persistence of worsened vasodilatation two months after TIPS. Hepatology. 20:1994;101A. abstract.
31. Wong F., Sniderman K., Liu P., Blendis L. Dissecting the factors involved in the pathogenesis of sodium retention in cirrhosis with ascites using TIPS. Hepatology. 22:1995;164A. abstract.
32. Sarfeh I.J., Rypins E.B., Fardi M., Conroy R.M., Mason G.R., Lyons K.P. Clinical implications of portal hemodynamics after small-diameter portocaval H-graft. Surgery. 96:1984;223-229.
33. Lee S.S., Johansen K., Lebrec D. Circulatory changes induced by portal venous diversion and mesenteric hypertension in rats. Hepatology. 15:1992;117-121.
34. Bichet D.G., Van Putten V.J., Schrier R.W. Potential role of increased sympathetic activity in impaired sodium and after excretion in cirrhosis. N Engl J Med. 307:1982;1552-1557.